Bank of America Corp DE cut its holdings in shares of SiriusPoint Ltd. (NYSE:SPNT – Free Report) by 71.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 58,114 ...

Bank of America Corp DE raised its stake in shares of McEwen Mining Inc (NYSE:MUX – Free Report) (TSE:MUX) by 74.9% during the fourth quarter, Holdings Channel reports. The firm owned 115,080 shares ...

I've been a Novo Nordisk bull for quite some time now, and I wouldn't be as spooked by the situation. Here's why. Novo Nordisk got a two-year-plus head start in the white-hot obesity drugs market, ...

Nvidia reported better-than-expected earnings and revenue on Wednesday, as the company's booming data center business ...

Macy’s beat earnings estimates for the first quarter, but cut its 2025 profit outlook as tariffs complicate its turnaround ...

Company sources said Toyota plans to increase PHEVs from 2.4% last year to roughly 20% of its U.S. sales volume by 2030.

Meta’s AI assistant now has one billion monthly active users across the company’s family of apps, CEO Mark Zuckerberg said ...

Assuming this is indeed what's happening, Noom's approach might boost Novo Nordisk sales of Wegovy as Noom becomes a reseller of Novo's drug. This would appear to offer a way for Noom (and other ...

On Wednesday, BofA Securities revised its price target for Novo Nordisk (CSE:NOVOb) (NOVOB:DC) (NYSE: NYSE:NVO) shares, lowering it to DKK850 from the previous DKK910. Despite the reduction, the firm ...

Such good fortune is affecting the companies which make them. Ozempic and Wegovy maker Novo Nordisk this week released its Q1 earnings, and it’s clear that GLP-1s are driving profits. Sales for the ...

which compares to analyst expectations of 18% sales growth and 23% operating profit growth. Bank of America analysts point out that currency hedging will help cushion the blow on Novo Nordisk's ...

U.S.-listed shares of Novo Nordisk are jumping in premarket trading Wednesday even as the Danish pharmaceutical giant lowered its full-year outlook.